Aliases & Classifications for Bronchiectasis

About this section

Aliases & Descriptions for Bronchiectasis:

Name: Bronchiectasis 10 47 12 36 24 65
Polynesian Bronchiectasis 10
 
Kartagener Syndrome 65

Classifications:



External Ids:

Disease Ontology10 DOID:9563
ICD1027 J47, J47.9
ICD9CM29 494
MeSH36 D001987
NCIt42 C84475
UMLS65 C0006267

Summaries for Bronchiectasis

About this section
Disease Ontology:10 A bronchial disease that is a chronic inflammatory condition of one or more bronchi or bronchioles marked by dilatation and loss of elasticity of the walls resulting from damage to the airway wall leading to the formation of small sacs on the bronchial wall and impairment of cilia mobility in the lung. Inflammation of the bronchial wall increases mucus secretion which serves as a breeding ground for bacteria. Bronchiectasis is caused by repeated respiratory infections, immune deficiency disorders, hereditary disorders (cystic fibrosis or primary ciliary dyskinesia), mechanical factors (inhaled object or a lung tumor) or inhaling toxic substances.

MalaCards based summary: Bronchiectasis, also known as polynesian bronchiectasis, is related to dextrocardia and idiopathic bronchiectasis, and has symptoms including headacheand anosmia. An important gene associated with Bronchiectasis is DNAI1 (Dynein Axonemal Intermediate Chain 1). The drug acetylcysteine has been mentioned in the context of this disorder. Affiliated tissues include lung, heart and neutrophil.

Wikipedia:68 Bronchiectasis is a disease in which there is permanent enlargement of parts of the airways of the lung.... more...

Related Diseases for Bronchiectasis

About this section

Diseases related to Bronchiectasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 170)
idRelated DiseaseScoreTop Affiliating Genes
1dextrocardia29.5ARMC4, C21orf59, CCDC103, CCDC114, CCNO, DNAAF1
2idiopathic bronchiectasis12.2
3bronchiectasis with or without elevated sweat chloride 212.1
4bronchiectasis with or without elevated sweat chloride 112.1
5bronchiectasis with or without elevated sweat chloride 312.1
6ciliary dyskinesia-bronchiectasis12.0
7bronchiectasis oligospermia11.9
8kartagener syndrome11.5
9primary ciliary dyskinesia11.2
10ciliary dyskinesia, primary, 1, with or without situs inversus11.2
11cystic fibrosis11.0
12multicentric osteolysis of torg10.7CCNO, MCIDAS
13williams-campbell syndrome10.5
14yellow nail syndrome10.4
15congenital adrenal insufficiency10.3CCDC114, DNAAF1, DNAH5, DNAI1, DNAI2, RSPH1
16nontuberculous mycobacterial lung disease10.3
17glottis verrucous carcinoma10.3DNAAF1, DNAH5, DNAI1, DNAI2, RSPH4A, RSPH9
18tracheobronchomegaly10.3
19asthma10.2
20lung disease10.2
21pneumonia10.1
22aspergillosis10.0
23sinusitis10.0
24allergic bronchopulmonary aspergillosis10.0
25tuberculosis10.0
26bronchitis10.0
27common variable immunodeficiency10.0
28gastroesophageal reflux9.9
29rheumatoid arthritis9.9
30alpha 1-antitrypsin deficiency9.9
31arthritis9.9
32esophagitis9.9
33influenza9.9
34ciliary dyskinesia, primary, 229.9
35ciliary dyskinesia, primary, 329.9
36cutis laxa, ad9.9
37ciliary dyskinesia, primary, 289.9
38ciliary dyskinesia, primary, 239.9
39ciliary dyskinesia, primary, 279.9
40ciliary dyskinesia, primary, 259.9
41ciliary dyskinesia, primary, 269.9
42young syndrome9.9
43inclusion body myopathy, autosomal recessive9.8ARMC4, C21orf59, CCDC103, CCDC114, CCNO, DNAAF1
44aspiration pneumonia9.8
45nasopharyngitis9.8
46agammaglobulinemia9.8
47thyroiditis9.8
48situs inversus9.8
49vasculitis9.8
50amyloidosis9.8

Comorbidity relations with Bronchiectasis via Phenotypic Disease Network (PDN):


Anxiety DisorderAspergillosis
EsophagitisIdiopathic Interstitial Pneumonia
Lung AbscessOsteoporosis
Postinflammatory Pulmonary FibrosisRespiratory Failure
Rheumatoid ArthritisBronchitis
BronchopneumoniaChronic Pulmonary Heart Disease
Deficiency AnemiaFamilial Atrial Fibrillation
Heart DiseaseHypothyroidism
Mitral Valve DiseasePrimary Agammaglobulinemia
Protein-Energy MalnutritionPulmonary Tuberculosis

Graphical network of the top 20 diseases related to Bronchiectasis:



Diseases related to bronchiectasis

Symptoms for Bronchiectasis

About this section

UMLS symptoms related to Bronchiectasis:


headache, anosmia

Drugs & Therapeutics for Bronchiectasis

About this section

Drugs for Bronchiectasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 136)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Tobramycinapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 111132986-56-45496, 36294
Synonyms:
1-Epitobramycin
11098-01-4
11111-45-8
3'-Deoxykanamycin B
3'-Deoxykanamycin b
32986-56-4
34337-51-4
37321-13-4
49842-07-1 (Sulfate)
54330-95-9
70322-33-7
79645-27-5
A 12253A
AB00513858
AC1L1KGY
AC1L1VI0
AC1O7GFJ
AC1Q2AOW
AKOS000715235
Aktob
BAS 00463364
BIDD:GT0503
BPBio1_000647
BRN 1357507
BSPBio_000587
BSPBio_002036
Bethkis
Brulamycin
C00397
C18H37N5O9
CAS-32986-56-4
CHEBI:28864
CHEBI:533587
CHEMBL1747
CID11340303
CID36294
CID5496
CID6604388
CID9804613
CID9934285
CPD000058793
D00063
DB00684
Deoxykanamycin B
Distobram
EINECS 251-322-5
Gotabiotic
HMS1569N09
HMS2090B16
HMS2092M17
HSDB 3259
KBio2_001552
KBio2_004120
KBio2_006688
KBio3_001536
KBioGR_001104
KBioSS_001552
Kitabis Pak
LS-146940
LS-187329
Lilly 47663
MLS000069544
MolPort-001-934-131
MolPort-003-665-548
MolPort-003-939-629
NCGC00016814-01
NCGC00178852-01
NCGC00178852-02
NEBRAMYCIN
NF 6
NSC 180514
 
NSC180514
Nebcin
Nebcin (Sulfate)
Nebicin
Nebramycin 6
Nebramycin VI
Nebramycin factir 6
Nebramycin factor 6
Nebramycin-Faktor 6
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine
Obracin
Obramycin
Prestwick0_000544
Prestwick1_000544
Prestwick2_000544
Prestwick3_000544
Prestwick_850
S2514_Selleck
SAM001246911
SMR000058793
SPBio_000295
SPBio_002508
SPECTRUM1500579
SPRC-AB01
STK182610
Spectrum2_000078
Spectrum3_000588
Spectrum4_000752
Spectrum5_001038
Spectrum_001072
Sybryx
T4014_SIGMA
TOA-(1-6)2TB-(4-1)TOC
TOA-(1-6)TOB-(4-1)TOC
TOBRAMYCIN SULFATE
TOY
Tenebrimycin
Tenemycin
Tobacin
Tobi
Tobi Podhaler
Tobracin
Tobracin (TN)
Tobracin (tn)
Tobradex
Tobradistin
Tobralex
Tobramaxin
Tobramicin
Tobramicina
Tobramicina [INN-Spanish]
Tobramitsetin
Tobramycetin
Tobramycin
Tobramycin (JP15/USP)
Tobramycin Sulfate
Tobramycin [USAN:BAN:INN:JAN]
Tobramycin for Inhalation
Tobramycin solution for inhalation
Tobramycin, Free Base
Tobramycine
Tobramycine [INN-French]
Tobramycinum
Tobramycinum [INN-Latin]
Tobrased
Tobrasone
Tobrex
Tobrex (TN)
Tobrex (tn)
UNII-VZ8RRZ51VK
tobramycin
tobramycin solution for inhalation
2
TheophyllineapprovedPhase 45658-55-92153
Synonyms:
1,3 Dimethylxanthine
1,3-Dimethylxanthine
1,3-dimethyl-7H-purine-2,6-dione
1,3-dimethylxanthine
111079-49-3
1H-purine-2,6-dione
2a3a
46157-00-0
56645-32-0
58-55-9
75448-53-2
AB00052106
AC-20328
AC1L1D1F
AI3-50216
AKOS000120961
Accurbron
Acet-theocin
Aerobin
Aerolate
Aerolate III
Aerolate SR
Afonilm
Afonilum
Afonilum Retard
Aminophylline
Aquaphyllin
Armophylline
Asbron
Asmalix
Asmax
Austyn
BCBcMAP01_000071
BIDD:ER0557
BIDD:GT0151
BPBio1_000791
BPBio1_001041
BSPBio_000719
BSPBio_000945
BSPBio_002363
Bilordyl
Bronchodid Duracap
Bronchoparat
Bronchoretard
Bronkodyl
Bronkodyl SR
Bronkotabs
C07130
C7H8N4O2
CCRIS 4729
CHEBI:28177
CHEMBL190
CID2153
CPD-12479
CPD000058537
Cetraphylline
Choledyl SA
Chronophyllin
Constant T
Constant-T
ConstantT
D00371
D013806
DB00277
Diffumal
Dimethylxanthine
Diphyllin
DivK1c_000203
Doraphyllin
Duraphyl
Duraphyllin
Dyspne-Inhal
EINECS 200-385-7
Egifilin
Elixex
Elixicon
Elixomin
Elixophyllin
Elixophyllin (TN)
Elixophyllin SR
Elixophyllin(e)
Elixophylline
Etheophyl
Euphylline
Euphylong
GS 2591A
HMS1921E03
HMS2089A06
HMS2092M05
HMS500K05
HSDB 3399
Hylate
IDI1_000203
KBio1_000203
KBio2_001518
KBio2_004086
KBio2_006654
KBio3_001583
KBioGR_000785
KBioSS_001518
L000595
LASMA
LS-241
LaBID
Labid
Labophylline
Lanophyllin
Liquophylline
Liquorice
Lopac0_000014
MLS000069390
MLS002152943
MLS002153487
Maphylline
Medaphyllin
MolPort-001-002-058
MolPort-001-737-342
Mudrane
NCGC00018117-01
NCGC00018117-16
NCGC00022112-03
NCGC00022112-04
NCGC00022112-05
NCGC00022112-07
NCGC00022112-08
NCGC00022112-09
NCGC00022112-10
NCGC00022112-11
NCI60_001736
NINDS_000203
NSC 2066
NSC2066
Nuelin
Nuelin S.A
Nuelin S.A.
Nuelin SA
Optiphyllin
PDSP1_001018
PDSP1_001234
PDSP2_001002
PDSP2_001218
Parkophyllin
Physpan
Prestwick0_000820
Prestwick0_000873
Prestwick1_000820
Prestwick1_000873
Prestwick2_000820
Prestwick2_000873
Prestwick3_000820
Prestwick3_000873
Pro-vent
Pseudotheophylline
Pulmidur
Pulmo-Timelets
 
Quibron
Quibron T
Quibron T SR
Quibron T-SR
Quibron T/SR
Quibron TSR
Quibron-T
Quibron-T/SR
Quibron-T/Sr
Quibron-t (TN)
Respbid
Respicur
Respid
S1621_Selleck
SAM002554935
SMP1_000291
SMR000058537
SPBio_000823
SPBio_002640
SPBio_002866
SPECTRUM1500568
ST024762
STK397040
Slo Phyllin
Slo-Bid
Slo-Phyllin
Slo-bid
Slo-phyllin
SloPhyllin
Solosin
Somophyllin CRT
Somophyllin T
Somophyllin-CRT
Somophyllin-Crt
Somophyllin-DF
Somophyllin-T
Somophyllin-t
SomophyllinT
Spectrum2_000842
Spectrum3_000672
Spectrum4_000353
Spectrum5_001232
Spectrum_001038
Spophyllin retard
Sustaire
Synophylate
Synophylate-L.A. Cenules
T-Phyl
T0179
T1633_SIGMA
T4924_SIGMA
T7770_SIGMA
T9031_SIGMA
THEOBID JR
Talotren
Tefamin
Telb-DS
Telbans Dry Syrup
Teocen 200
Teofilina
Teofilina [Polish]
Teofyllamin
Teolair
Teonova
Teosona
Tesona
Theacitin
Theal tabl.
Theal tablets
Theo 24
Theo Dur
Theo-11
Theo-24
Theo-24 (TN)
Theo-DS
Theo-Dur
Theo-Dur-Sprinkle
Theo-Nite
Theo-Organidin
Theo-Sav
Theo-dur
Theo24
Theobid
Theobid Duracap
Theobid Jr.
Theochron
Theocin
Theoclair-SR
Theoclear
Theoclear 80
Theoclear L.A.-130
Theoclear LA
Theoclear-200
Theoclear-80
Theocontin
Theodel
Theodrip
Theodur
Theodur Dry Syrup
Theodur G
Theodur G (TN)
Theofol
Theograd
Theokin
Theolair
Theolair (TN)
Theolair-SR
Theolair-Sr
Theolix
Theolixir
Theona P
Theonite
Theopek
Theophyl
Theophyl-225
Theophyl-SR
Theophyl-Sr
Theophyline
Theophyllin
Theophylline
Theophylline (Anhydrous)
Theophylline (JP15)
Theophylline Anhydrous
Theophylline Extended Release
Theophylline anhydrous
Theophylline(anhydrous)
Theophylline-SR
Theophylline-Sr
Theophylline-[8-3H
Theoplus
Theospan
Theostat
Theostat 80
Theotard
Theovent
UNII-0I55128JYK
UPCMLD-DP123
UPCMLD-DP123:001
Uni-Dur
Unifyl
Unilong
Uniphyl
Uniphyl (TN)
Uniphyllin
Uniphyllin continus
Uniphylline
X 115
Xanthium
Xantivent
ZINC18043251
aminophylline
ct, theo von
nchembio.273-comp2
theo von ct
theophylline
von ct, theo
3
AzithromycinapprovedPhase 4, Phase 3, Phase 2, Phase 132283905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
4
BudesonideapprovedPhase 438151333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide Inhalation
Budesonide MMX
Budesonide Nasal
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
 
Horacort
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort FLEXHALER
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Uceris
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
5
AmikacinapprovedPhase 4, Phase 1, Phase 25837517-28-537768
Synonyms:
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-4-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
(2S)-4-amino-N-{(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-4-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide
1-N-(L(-)-gamma-Amino-alpha-hydroxybutyryl)kanamycin A
1-N-(L(-)-gamma-amino-alpha-Hydroxybutyryl)kanamycin a
108914-65-4
110660-81-6
110660-83-8
111319-93-8
37517-28-5
38859-32-4
AB00513828
AC1L1YE8
AC1Q5JTM
AMIKACIN SULFATE
ANTIBIOTIC BB-K8
Amicacin
Amiglyde-V
Amiglyde-v
Amikacin
Amikacin & Tumor Necrosis Factor
Amikacin (USP)
Amikacin (USP/INN)
Amikacin Base
Amikacin Dihydrate
Amikacin Sulfate
Amikacin [USAN:BAN:INN]
Amikacina
Amikacina [INN-Spanish]
Amikacine
Amikacine [INN-French]
Amikacinum
Amikacinum [INN-Latin]
Amikavet
 
Amikin
Amikin (Disulfate)
Antibiotic BB-K 8
Arikace
BB-K 8
BB-K8
BPBio1_000671
BSPBio_000609
Briclin
C06820
C22H43N5O13
CHEBI:2637
CHEMBL177
CID37768
D02543
DB00479
EINECS 253-538-5
HSDB 3583
Kaminax
LS-146896
Lukadin
Mikavir
MolPort-000-761-900
NCGC00093350-02
NCGC00093350-03
NSC 177001
NSC177001
O-3-Amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1->4)]-1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-6))-N(sup 3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
O-3-amino-3-Deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
Prestwick3_000395
STK039706
UNII-84319SGC3C
amikacin
amikacine
6
Meropenemapproved, investigationalPhase 481119478-56-764778, 441130
Synonyms:
(1R,5S,6S)-2-[(3S,5S)-5-(dimethylaminocarbonyl)pyrrolidin-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid trihydrate
(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid
(2S,3R,4R)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-{[(3S,5R)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid
(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5S,6S)-3-((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-ylthio)-6-((S)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(6S)-2-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-1beta-methyl-2,3-didehydro-1-carbapenam-3-carboxylic acid
96036-03-2
AB00514051
AB1004614
AC1L9ALL
Ambap119478-56-7
Antibiotic SM 7338
Antibiotic sm 7338
BIDD:GT0851
BPBio1_001334
BSPBio_001212
CHEBI:43968
CHEMBL127
CID441130
CPD000469184
D08185
HMS1571M14
HMS2051G08
HMS2090C05
 
ICI-194660
MEPM
MERONEM
MLS001401437
Meronem (TN)
Meropen
Meropenem
Meropenem (INN)
Meropenem Hydrate
Meropenem anhydrous
Meropenem trihydrate
Meropenemum
Meropenemum [INN-Latin]
Meropenemum trihydricum
Merrem
Merrem I.V. (TN)
Merrem IV
MolPort-006-709-417
NCGC00179259-01
Prestwick0_001106
Prestwick1_001106
Prestwick2_001106
Prestwick3_001106
SAM001246650
SM-7338
SMR000469184
SPBio_003086
7
AcetylcysteineapprovedPhase 4293616-91-112035
Synonyms:
(2R)-2-acetylamino-3-Sulfanylpropanoic acid
(R)-2-acetylamino-3-Mercaptopropanoic acid
(R)-Mercapturic acid
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
ACC
Acetadote
Acetilcisteina
Acetylcysteine
Acetylcysteinum
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumucetin
 
Fluprowit
L-Acetylcysteine
L-alpha-acetamido-beta-Mercaptopropionic acid
Lysox
Mercapturic acid
Mucolysin
Mucomyst
N-ACETYL-L-cysteine
N-Acety-L-Cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-L-(+)-cysteine
N-Acetylcysteine
N-acetylcysteine
NAC
Parvolex
Sodium 2-acetamido-3-mercaptopropionate
8
Ergocalciferolapproved, nutraceuticalPhase 492350-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
9
Cholecalciferolapproved, nutraceuticalPhase 479967-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
 
Colecalciferol
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
calciol
cholecalciferol
delta-D
vitamin d-3
10ExpectorantsPhase 4, Phase 2337
11Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 117220
12Hypolipidemic AgentsPhase 42228
13Calcium, DietaryPhase 44678
14Protective AgentsPhase 45651
15Hydroxymethylglutaryl-CoA Reductase InhibitorsPhase 41804
16GentamicinsPhase 4123
17AntioxidantsPhase 42442
18ImmunoglobulinsPhase 4, Phase 34477
19Immunologic FactorsPhase 4, Phase 318483
20Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3440
21AntibodiesPhase 4, Phase 34477
22VaccinesPhase 4, Phase 36085
23Atorvastatin CalciumPhase 4714134523-03-8
24Adrenergic AgentsPhase 44204
25Pharmaceutical SolutionsPhase 4, Phase 3, Phase 2, Phase 17004
26Formoterol FumaratePhase 4385
27Bronchodilator AgentsPhase 4, Phase 22377
28Anti-Inflammatory AgentsPhase 4, Phase 28478
29Anti-Asthmatic AgentsPhase 4, Phase 22796
30glucocorticoidsPhase 43896
31Neurotransmitter AgentsPhase 414795
32HormonesPhase 411748
33Hormone AntagonistsPhase 410002
34AntimetabolitesPhase 49454
35Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 49988
36Adrenergic beta-AgonistsPhase 41266
37Adrenergic beta-2 Receptor AgonistsPhase 4741
38Vasodilator AgentsPhase 42926
39Anti-Bacterial AgentsPhase 4, Phase 3, Phase 2, Phase 19140
40Antibiotics, AntitubercularPhase 4, Phase 3, Phase 25971
41Anticholesteremic AgentsPhase 41732
42Respiratory System AgentsPhase 4, Phase 23931
43Purinergic P1 Receptor AntagonistsPhase 4262
44Peripheral Nervous System AgentsPhase 4, Phase 218510
45Phosphodiesterase InhibitorsPhase 41062
46Adrenergic AgonistsPhase 42331
47VitaminsPhase 43857
48ErgocalciferolsPhase 4923
49Cholinergic AntagonistsPhase 41423
50Cholinergic AgentsPhase 43243

Interventional clinical trials:

(show top 50)    (show all 185)
idNameStatusNCT IDPhase
1The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of BronchiectasisCompletedNCT01769898Phase 4
2Efficacy of Azithromycin in Treatment of BronchiectasisCompletedNCT02107274Phase 4
3The Effect of Theophylline in the Treatment of BronchiectasisCompletedNCT01684683Phase 4
4Is Regular Chest Physiotherapy an Effective Treatment in Severe, Non Cystic Fibrosis Bronchiectasis?CompletedNCT00816309Phase 4
5Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis BronchiectasisCompletedNCT02782312Phase 4
6Pulmonary Rehabilitation in Non Cystic Fibrosis BronchiectasisCompletedNCT00868075Phase 4
7A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis BronchiectasisCompletedNCT01299181Phase 4
8Long Term Nebulised Gentamicin in Patients With BronchiectasisCompletedNCT00749866Phase 4
9Efficacy of Temporary Positive Expiratory Pressure (TPEP) in Chronic HypersecretionCompletedNCT00700388Phase 4
10Effectiveness and Safety of Inhaling Hypertonic Saline in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00639236Phase 4
11Bacterial Load Guided Therapy for Severe Bronchiectasis ExacerbationsRecruitingNCT02047773Phase 4
12A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With BronchiectasisRecruitingNCT01677403Phase 4
13Comparisons of Inhaled LAMA or ICS+LABA for COPD With BronchiectasisRecruitingNCT02546297Phase 4
14Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis BronchiectasisRecruitingNCT02507843Phase 4
15Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of BronchiectasisRecruitingNCT02509091Phase 4
16Macrolide Mediates Pulmonary Infection of Pseudomonas AeruginosaRecruitingNCT02491723Phase 4
17Polysaccharide Antibody Response StudyRecruitingNCT02429531Phase 4
18Atorvastatin in Bronchiectasis in Patients With Pseudomonas AeruginosaActive, not recruitingNCT01299194Phase 4
19Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis BronchiectasisActive, not recruitingNCT02081963Phase 4
20Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of BronchiectaisisActive, not recruitingNCT02088216Phase 4
21Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)Active, not recruitingNCT01830959Phase 4
22Hospitalised Pneumonia With Extended Treatment (HOPE) StudyNot yet recruitingNCT02783859Phase 4
23Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)CompletedNCT01764841Phase 3
24Safety and Efficacy of Bronchitol in BronchiectasisCompletedNCT00277537Phase 3
25Inhaled Mannitol as a Mucoactive Therapy for BronchiectasisCompletedNCT00669331Phase 3
26The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis BronchiectasisCompletedNCT00484263Phase 3
27Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis BronchiectasisCompletedNCT01313624Phase 3
28Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis BronchiectasisCompletedNCT01314716Phase 3
29Efficacy and Safety Study of a Percussion Device to Mobilise Sputum From Respiratory PassageCompletedNCT01480882Phase 2, Phase 3
30EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft RejectionCompletedNCT00105183Phase 3
31Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of AG1321001 in Chronic CougherCompletedNCT00380315Phase 3
32Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)CompletedNCT00656409Phase 3
33Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CFCompletedNCT01641822Phase 3
34Prevention of Bronchiectasis in Infants With Cystic FibrosisRecruitingNCT01270074Phase 3
35Prevention of OM-85 on Bronchiectasis ExacerbationRecruitingNCT01968421Phase 3
36The Role of Inhalations of Tranexamic Acid in Patients With HemoptysisRecruitingNCT01496196Phase 3
37An Open Label Trial of Azithromycin in Chronic Productive CoughRecruitingNCT02196493Phase 3
38Effects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalizationRecruitingNCT01973998Phase 3
39Bronchiectasis and Long Term Azithromycin TreatmentActive, not recruitingNCT00415350Phase 3
40Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)Active, not recruitingNCT02106832Phase 3
41Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF BronchiectasisActive, not recruitingNCT02104245Phase 3
42The Efficacy of Azithromycin in Treating Children With Non Cystic Fibrosis BronchiectasisActive, not recruitingNCT02531984Phase 3
43Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF BronchiectasisActive, not recruitingNCT01515007Phase 3
44Inhaled Nebulized Tobramycin in Non-cystic Fibrosis BronchiectasisNot yet recruitingNCT02657473Phase 2, Phase 3
45Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis BronchiectasisCompletedNCT02035488Phase 1, Phase 2
46Physical Capacity in Patients With Bronchiectasis Before and After Rehabilitation ProgramCompletedNCT02208830Phase 1, Phase 2
47Evaluation of the Effect of AZD5069 in Patients With BronchiectasisCompletedNCT01255592Phase 2
48A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With BronchiectasisCompletedNCT00769119Phase 2
49A Study to Determine the Safety and Tolerability of Arikace™ Versus Placebo in Patients Who Have Bronchiectasis.CompletedNCT00775138Phase 1, Phase 2
50Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With BronchiectasisCompletedNCT00805025Phase 2

Search NIH Clinical Center for Bronchiectasis

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: bronchiectasis

Genetic Tests for Bronchiectasis

About this section

Anatomical Context for Bronchiectasis

About this section

MalaCards organs/tissues related to Bronchiectasis:

33
Lung, Heart, Neutrophil, Testes, Breast, Brain, Prostate

Animal Models for Bronchiectasis or affiliated genes

About this section

Publications for Bronchiectasis

About this section

Articles related to Bronchiectasis:

(show top 50)    (show all 719)
idTitleAuthorsYear
1
Assessment of the quantity of microorganisms associated with bronchiectasis in saliva, sputum and nasal lavage after periodontal treatment: a study protocol of a randomised controlled trial. (27084279)
2016
2
Phenotyping bronchiectasis: is it all about sputum and infection? (27037310)
2016
3
The development of bronchiectasis on chest computed tomography in children with cystic fibrosis: can pre-stages be identified? (27108295)
2016
4
Asthma and bronchiectasis exacerbation. (27076584)
2016
5
A rare cause of bronchiectasis. (25849059)
2015
6
Quality of Life and Bronchial Hyper-Responsiveness in Subjects With Bronchiectasis: Validation of the Seattle Obstructive Lung Disease Questionnaire in Bronchiectasis. (26199452)
2015
7
Impact of Different Etiologies of Bronchiectasis on the Pulmonary Function Tests. (25380609)
2014
8
The prevalence of bronchiectasis in patients with Marfan syndrome. (25199019)
2014
9
Expression of soluble triggering receptor expressed on myeloid cells-1 in childhood CF and Non-CF bronchiectasis. (25348906)
2014
10
Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores. (25323621)
2014
11
Epicardially originating ventricular tachycardia: an unusual presentation of bronchiectasis. (23365070)
2013
12
Validation of a Quality of Life Questionnaire for Bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0. (24142190)
2013
13
Molecular epidemiological analysis suggests cross infection with Pseudomonas aeruginosa is rare in Non-Cystic Fibrosis bronchiectasis. (24176999)
2013
14
Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life. (22544417)
2013
15
Surgical treatment of bronchiectasis: a retrospective observational study of 138 patients. (23825752)
2013
16
Lung transplantation for cystic fibrosis and bronchiectasis. (23821505)
2013
17
Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis. (23401398)
2013
18
Mannose-binding lectin and innate immunity in bronchiectasis. (24429113)
2013
19
Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial. (23421781)
2013
20
Pulmonary rehabilitation for patients with bronchiectasis: case reports. (22510678)
2012
21
Focal bronchiectasis causing abnormal pulmonary radioiodine uptake in a patient with well-differentiated papillary thyroid carcinoma. (23097725)
2012
22
Bronchiectasis in chronic pulmonary aspiration: risk factors and clinical implications. (22028069)
2012
23
Pathogenesis of bronchiectasis. (22640841)
2012
24
Immune regulation in idiopathic bronchiectasis. (23231716)
2012
25
Inhaled gentamicin in non-cystic fibrosis bronchiectasis: effects of long-term therapy. (21470074)
2011
26
Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases. (22046967)
2011
27
Infection and remodelling: a 21st century model of bronchiectasis? (21965500)
2011
28
Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century. (20709772)
2010
29
Pneumatosis intestinalis presenting with a pneumoperitoneum in a patient with chronic bronchiectasis: a delayed diagnosis of superior mesenteric artery ischaemia. (22767661)
2010
30
British Thoracic Society guideline for non-CF bronchiectasis. (20627912)
2010
31
Cardiac herniation following completion pneumonectomy for bronchiectasis. (20826968)
2010
32
Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. (20854242)
2010
33
A decade of non-cystic fibrosis bronchiectasis 1996-2006. (20666070)
2010
34
Respiratory bacterial pathogens in the nasopharynx and lower airways of Australian indigenous children with bronchiectasis. (20656297)
2010
35
Stable bronchiectasis is associated with low serum L-ficolin concentrations. (20298369)
2009
36
Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. (19616787)
2009
37
Exhaled breath condensate MMP-9 levels in children with bronchiectasis. (19725099)
2009
38
Bronchiectasis: pathophysiology, presentation and management. (18837280)
2008
39
Congenital lymphoedema, bronchiectasis and seizure: case report. (18663889)
2008
40
Bronchiectasis, part 2: Management. (20046814)
2008
41
Re: A retrospective study of the relationship between tracheal collapse and bronchiectasis in dogs. (18018738)
2007
42
IFN gamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. (17026468)
2006
43
Bronchiectasis worsening by p-ANCA (bactericidal/permeability-increasing protein) positive vasculitis. A case report and review of the literature]. (16610259)
2005
44
Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis. (14985560)
2004
45
CFTR gene mutations in adults with disseminated bronchiectasis. (9272738)
1997
46
Bronchiectasis and homozygous (P1ZZ) alpha 1-antitrypsin deficiency. (8711667)
1996
47
Sputum sol phase proteins and elastase activity in patients with clinically stable bronchiectasis. (1372451)
1992
48
Simulated dextrocardia associated with bronchiectasis; report of case. (20280493)
1946
49
Dextrocardia and bronchiectasis, a review of the literature and a report of two cases. (20996259)
1946
50

Variations for Bronchiectasis

About this section

Clinvar genetic disease variations for Bronchiectasis:

5 (show all 60)
id Gene Variation Type Significance SNP ID Assembly Location
1CCNONM_021147.4(CCNO): c.248_252dupTGCCC (p.Gly85Cysfs)duplicationPathogenicrs587777498GRCh38Chr 5, 55233272: 55233276
2CCNONM_021147.4(CCNO): c.258_262dupGGCCC (p.Gln88Argfs)duplicationPathogenicrs587777499GRCh38Chr 5, 55233262: 55233266
3CCNONM_021147.4(CCNO): c.926delC (p.Pro309Argfs)deletionPathogenicrs587777500GRCh38Chr 5, 55231502: 55231502
4CCNONM_021147.4(CCNO): c.961C> T (p.Gln321Ter)single nucleotide variantPathogenicrs587777501GRCh38Chr 5, 55231467: 55231467
5CCNONM_021147.4(CCNO): c.263_267dupAGCCC (p.Val90Serfs)duplicationPathogenicrs587777502GRCh38Chr 5, 55233257: 55233261
6CCNONM_021147.4(CCNO): c.481_482delCT (p.Leu161Glyfs)deletionPathogenicrs587777503GRCh38Chr 5, 55232446: 55232447
7CCDC151NM_145045.4(CCDC151): c.925G> T (p.Glu309Ter)single nucleotide variantPathogenicrs587777779GRCh38Chr 19, 11426182: 11426182
8CCDC151NM_145045.4(CCDC151): c.1256C> A (p.Ser419Ter)single nucleotide variantPathogenicrs587777780GRCh37Chr 19, 11533390: 11533390
9DNAH8NM_001206927.1(DNAH8): c.2419C> T (p.Arg807Ter)single nucleotide variantPathogenicrs567050969GRCh38Chr 6, 38786788: 38786788
10DNAAF2NM_018139.2(DNAAF2): c.1199_1214dup16 (p.Gly406Argfs)duplicationPathogenicrs397515341GRCh38Chr 14, 49633936: 49633951
11DNAH5NM_001369.2(DNAH5): c.4348C> T (p.Gln1450Ter)single nucleotide variantPathogenicrs771663107GRCh37Chr 5, 13865784: 13865784
12DNAAF2NM_018139.2(DNAAF2): c.31delG (p.Glu11Argfs)deletionPathogenicrs797045146GRCh38Chr 14, 49635119: 49635119
13RSPH4ANM_001010892.2(RSPH4A): c.166dupC (p.Arg56Profs)duplicationPathogenicrs797045147GRCh37Chr 6, 116937952: 116937952
14RSPH4ANM_001010892.2(RSPH4A): c.921+3_921+6delAAGT (p.Tyr230GlnfsTer8)deletionPathogenic
15LRRC6NM_012472.5(LRRC6): c.630delG (p.Trp210Cysfs)deletionPathogenicrs760123202GRCh37Chr 8, 133645009: 133645009
16ARMC4NM_018076.4(ARMC4): c.1669G> T (p.Glu557Ter)single nucleotide variantPathogenicrs145742175GRCh37Chr 10, 28233225: 28233225
17RSPH1NM_080860.3(RSPH1): c.366G> A (p.Arg122=)single nucleotide variantPathogenicrs797045148GRCh37Chr 21, 43905914: 43905914
18RSPH1NM_080860.3(RSPH1): c.727+5G> A (p.Ala244ValfsTer22)single nucleotide variantPathogenicrs200382776GRCh37Chr 21, 43897396: 43897396
19SPAG1NM_172218.2(SPAG1): c.902_906delAAGTA (p.Lys301Thrfs)deletionPathogenicrs797045149GRCh37Chr 8, 101203687: 101203691
20C21orf59NM_021254.2(C21orf59): c.735C> G (p.Tyr245Ter)single nucleotide variantPathogenicrs202094637GRCh38Chr 21, 32602299: 32602299
21CCDC65NP_149115.2: p.Ile293ProfsTer2deletionPathogenic
22CCNONM_021147.4(CCNO): c.716A> G (p.His239Arg)single nucleotide variantPathogenicrs797045150GRCh37Chr 5, 54527540: 54527540
23DNAH1NM_015512.4(DNAH1): c.3460A> C (p.Lys1154Gln)single nucleotide variantPathogenicrs544674332GRCh37Chr 3, 52387629: 52387629
24MCIDASNM_001190787.1(MCIDAS): c.441C> A (p.Cys147Ter)single nucleotide variantPathogenicrs777031813GRCh37Chr 5, 54518169: 54518169
25MCIDASNM_001190787.1(MCIDAS): c.1097G> A (p.Gly366Asp)single nucleotide variantPathogenicrs797045151GRCh37Chr 5, 54516255: 54516255
26MCIDASNM_001190787.1(MCIDAS): c.1142G> A (p.Arg381His)single nucleotide variantPathogenicrs797045152GRCh37Chr 5, 54516210: 54516210
27RSPH3NM_031924.4(RSPH3): c.631-2A> Gsingle nucleotide variantPathogenicrs142800871GRCh37Chr 6, 159407455: 159407455
28DNAAF1NM_178452.5(DNAAF1): c.1349dupC (p.Pro451Alafs)duplicationPathogenicrs397515339GRCh37Chr 16, 84203783: 84203783
29DNAAF1NM_178452.5(DNAAF1): c.524T> G (p.Leu175Arg)single nucleotide variantPathogenicrs267607227GRCh37Chr 16, 84188353: 84188353
30DNAL1NM_031427.3(DNAL1): c.449A> G (p.Asn150Ser)single nucleotide variantPathogenicrs387907021GRCh37Chr 14, 74156135: 74156135
31DNAAF3NM_001256714.1(DNAAF3): c.386T> C (p.Leu129Pro)single nucleotide variantPathogenicrs387907151GRCh37Chr 19, 55677272: 55677272
32DNAAF3NM_001256714.1(DNAAF3): c.469C> T (p.Arg157Ter)single nucleotide variantPathogenicrs387907152GRCh37Chr 19, 55676795: 55676795
33DNAAF3NM_001256714.1(DNAAF3): c.825dupT (p.Val276Cysfs)duplicationPathogenicrs397515395GRCh37Chr 19, 55673053: 55673053
34CCDC103NM_213607.2(CCDC103): c.383dupG (p.Pro129Serfs)duplicationPathogenicrs587776910GRCh37Chr 17, 42979839: 42979839
35CCDC103NM_213607.2(CCDC103): c.461A> C (p.His154Pro)single nucleotide variantPathogenicrs145457535GRCh37Chr 17, 42979917: 42979917
36CCDC114NM_144577.3(CCDC114): c.742G> A (p.Ala248Thr)single nucleotide variantPathogenicrs147718607GRCh37Chr 19, 48807210: 48807210
37HYDINNM_001270974.2(HYDIN): c.3985G> T (p.Val1329Leu)single nucleotide variantPathogenicrs397515413GRCh37Chr 16, 71022036: 71022036
38HYDINNM_001270974.2(HYDIN): c.922A> T (p.Lys308Ter)single nucleotide variantPathogenicrs397515414GRCh37Chr 16, 71171175: 71171175
39DNAI2NM_023036.4(DNAI2): c.346-3T> G (p.Ile116GlyfsTer54)single nucleotide variantPathogenicrs397515358GRCh37Chr 17, 72283113: 72283113
40DNAAF2NM_018139.2(DNAAF2): c.23C> A (p.Ser8Ter)single nucleotide variantPathogenicrs137853191GRCh37Chr 14, 50101845: 50101845
41DRC1NM_145038.4(DRC1): c.2056A> T (p.Lys686Ter)single nucleotide variantPathogenicrs587776997GRCh37Chr 2, 26677651: 26677651
42DRC1NM_145038.4(DRC1): c.352C> T (p.Gln118Ter)single nucleotide variantPathogenicrs142371860GRCh37Chr 2, 26644264: 26644264
43DNAI1NM_012144.3(DNAI1): c.48+2dupT (p.Ser17ValfsTer12)duplicationPathogenicrs397515363GRCh37Chr 9, 34459053: 34459053
44DNAI1NM_012144.3(DNAI1): c.282_283insAATA (p.Gly95Asnfs)insertionPathogenicrs606231164GRCh38Chr 9, 34489343: 34489344
45DNAI1NM_012144.3(DNAI1): c.1543G> A (p.Gly515Ser)single nucleotide variantPathogenicrs79833450GRCh37Chr 9, 34513163: 34513163
46DNAI1NM_012144.3(DNAI1): c.1658_1669delCCAAGGTCTTCA (p.Thr553_Phe556del)deletionPathogenicrs606231165GRCh38Chr 9, 34514482: 34514493
47DNAI1NM_012144.3(DNAI1): c.1490G> A (p.Gly497Asp)single nucleotide variantPathogenicrs376252276GRCh37Chr 9, 34513110: 34513110
48DNAI1NM_012144.3(DNAI1): c.2001+1G> A (p.Ala607_Lys667del)single nucleotide variantPathogenicrs397515563GRCh37Chr 9, 34517466: 34517466
49DNAI2NM_023036.4(DNAI2): c.1494+1G> C (p.Val450_Ser498del)single nucleotide variantPathogenicrs397515565GRCh37Chr 17, 72306303: 72306303
50ZMYND10NM_015896.3(ZMYND10): c.47T> G (p.Val16Gly)single nucleotide variantPathogenicrs138815960GRCh37Chr 3, 50382964: 50382964
51ZMYND10NM_015896.3(ZMYND10): c.797T> C (p.Leu266Pro)single nucleotide variantPathogenicrs200913791GRCh37Chr 3, 50379904: 50379904
52ARMC4NM_018076.4(ARMC4): c.2780T> G (p.Leu927Trp)single nucleotide variantPathogenicrs587777047GRCh37Chr 10, 28151382: 28151382
53RSPH1NM_080860.3(RSPH1): c.85G> T (p.Glu29Ter)single nucleotide variantPathogenicrs138320978GRCh37Chr 21, 43913159: 43913159
54RSPH1NM_080860.3(RSPH1): c.366-3C> Asingle nucleotide variantPathogenicrs587777058GRCh37Chr 21, 43905917: 43905917
55RSPH1NM_080860.3(RSPH1): c.407_410delAGTA (p.Lys136Metfs)deletionPathogenicrs587777059GRCh37Chr 21, 43905870: 43905873
56RSPH1NM_080860.3(RSPH1): c.275-2A> C (p.Gly92AlafsTer10)single nucleotide variantPathogenicrs151107532GRCh37Chr 21, 43906573: 43906573
57RSPH9NM_152732.4(RSPH9): c.804_806delGAA (p.Lys268del)deletionPathogenicrs397515340GRCh37Chr 6, 43638659: 43638661
58SPAG1NM_172218.2(SPAG1): c.2014C> T (p.Gln672Ter)single nucleotide variantPathogenicrs201740530GRCh37Chr 8, 101245664: 101245664
59C21orf59NM_021254.2(C21orf59): c.292C> T (p.Arg98Ter)single nucleotide variantPathogenicrs143740376GRCh37Chr 21, 33982163: 33982163
60C21orf59NM_021254.2(C21orf59): c.792_795delTTTA (p.Tyr264Terfs)deletionPathogenicrs398122401GRCh37Chr 21, 33974251: 33974254

Expression for genes affiliated with Bronchiectasis

About this section
Search GEO for disease gene expression data for Bronchiectasis.

Pathways for genes affiliated with Bronchiectasis

About this section

GO Terms for genes affiliated with Bronchiectasis

About this section

Cellular components related to Bronchiectasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1axonemeGO:000593010.4ARMC4, CCDC114, RSPH4A
2outer dynein armGO:003615710.4CCDC114, DNAI2
3motile ciliumGO:003151410.3RSPH1, RSPH4A
4sperm flagellumGO:003612610.1DNAI2, RSPH1

Biological processes related to Bronchiectasis according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1inner dynein arm assemblyGO:003615910.7CCDC103, ZMYND10
2determination of digestive tract left/right asymmetryGO:007190710.7CCDC103, DNAAF1
3outer dynein arm assemblyGO:003615810.6DNAAF1, LRRC6
4motile cilium assemblyGO:004445810.6DNAAF1, MCIDAS, RSPH9
5epithelial cilium movement involved in determination of left/right asymmetryGO:006028710.6CCDC103, DNAAF1, LRRC6
6sperm motilityGO:003031710.5DNAI1, LRRC6
7multi-ciliated epithelial cell differentiationGO:190325110.4CCNO, MCIDAS
8cilium-dependent cell motilityGO:006028510.4DNAAF2, DRC1
9cilium assemblyGO:004238410.2CCNO, DNAH5, DNAI2
10axonemal dynein complex assemblyGO:007028610.0DNAAF1, DNAAF2, DRC1

Sources for Bronchiectasis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet